A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

As the adage goes, the eyes are the windows to the soul. So what does it mean to wish yours were a different color? Apparently enough people share this desire to create a bustling market for ...

Surrozen said despite SZN-043 demonstrating changes in liver function assays, there was not enough clinical benefit for ...

Retinitis pigmentosa (RP) is a rare inherited condition that causes the gradual death of photoreceptors (light-sensing cells) ...

DelveInsight's "VUITY Market Size, Forecast, and Market Insight Report" highlights the details around VUITY, which is a ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.

The risk of systemic side effects is greater in infants than in adults due to increased percutaneous drug absorption and lower blood volume. The closed eyes technique of eyedrop administration is ...